0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Cardiovascular medicine

Buy Now

Angiotensin II Receptor Blockade Physiological and Clinical Implications (Paperback, Softcover reprint of the original 1st ed. 1998) Loot Price: R8,380
Discovery Miles 83 800
Angiotensin II Receptor Blockade Physiological and Clinical Implications (Paperback, Softcover reprint of the original 1st ed....

Angiotensin II Receptor Blockade Physiological and Clinical Implications (Paperback, Softcover reprint of the original 1st ed. 1998)

Naranjan S. Dhalla, Peter Zahradka, Ian M.C. Dixon, Robert E. Beamish

Series: Progress in Experimental Cardiology, 2

 (sign in to rate)
Loot Price R8,380 Discovery Miles 83 800 | Repayment Terms: R785 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

The relationship between angiotensin II and hypertension was established in 1898 when angiotensin II was shown to modulate systemic blood pressure. Over the intervening decades, a complete characterization of the renin-angiotensin system (RAS) has been achieved, and our understanding of its biochemistry and physiology has led to the directed development of agents such as ACE inhibitors and receptor antagonists capable of controlling hypertension. More recently, it was shown that angiotensin II is secreted within certain tissues, and that these tissue-specific systems operate independently of the systemic RAS. The novel concept that angiotensin II regulates a number of cardiovascular processes that are unrelated to blood pressure has renewed the interest of both basic and clinical scientists in angiotensin II. The association between angiotensin II and cardiac growth, in particular, has indicated that therapies currently in use for hypertension may have direct application to the treatment of heart failure.Angiotensin II Receptor Blockade: Physiological and Clinical Implications focuses on the most recent developments in the molecular biology, cellular physiology and structure-function relationships of angiotensin II and its receptors. In addition, this volume covers the current therapeutic uses for angiotensin receptor antagonists and considers their potential future applications. This volume will be a valuable resource for scientists, practising clinicians and students who are attempting to extend their knowledge in the field of hypertension and heart failure, and who are devoted to improving cardiovascular health.

General

Imprint: Springer-Verlag New York
Country of origin: United States
Series: Progress in Experimental Cardiology, 2
Release date: March 2013
First published: 1998
Editors: Naranjan S. Dhalla • Peter Zahradka • Ian M.C. Dixon • Robert E. Beamish
Dimensions: 235 x 155 x 32mm (L x W x T)
Format: Paperback
Pages: 588
Edition: Softcover reprint of the original 1st ed. 1998
ISBN-13: 978-1-4613-7631-6
Categories: Books > Medicine > Clinical & internal medicine > Cardiovascular medicine
Promotions
LSN: 1-4613-7631-9
Barcode: 9781461376316

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners